UTI S&P BSE Sensex ETF
Ticker: UTISENSETF
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
885.17
Market Cap
15503.00
Debt/Equity
ROE %
PB
Promoter %
Pledge %
1Y Rev Growth %
5Y Rev Growth %
NP Margin %
NP Margin 5Y Avg %
Trading Reference
1M Return %
-1.334
6M Return %
5.252
1Y Return %
-5.036
% Away 52W High
6.160
% Away 52W Low
13.491
Daily Volume
1622
Investment Verdict
Avoid
Score 0/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 17/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
80%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
The UTI S&P BSE Sensex ETF is currently trading near a significant support level, with the 50-day EMA showing a bullish crossover above the 200-day EMA. Volume has been increasing, indicating strong buying interest. Therefore, there is a favorable probability for the ETF to appreciate in the medium term, with potential resistance levels ahead.
Upside Probability: 15% | Downside Probability: 5%
Probability estimates are technical-context statements, not investment advice.
More Options
N
Natco Pharma Ltd
Natco Pharma Ltd shows decent potential with a solid business model and growth prospects, but faces challenges in profitability and valuation metrics.
View details
C
CIE Automotive India Ltd
CIE Automotive India Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
A
Akzo Nobel India Ltd
Akzo Nobel India Ltd shows decent fundamentals but faces challenges in profitability and market sentiment.
View details
N
Nuvoco Vistas Corporation Ltd
Nuvoco Vistas Corporation Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
A
Allied Blenders and Distillers Ltd
Allied Blenders and Distillers Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
B
Bls International Services Ltd
Bls International Services Ltd shows potential but has several risks that need to be addressed for sustainable growth.
View details
D
Data Patterns (India) Ltd
Data Patterns (India) Ltd shows potential for growth in a future-ready sector, but valuation concerns and execution risks warrant caution.
View details
C
City Union Bank Ltd
City Union Bank Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
View details
N
Niva Bupa Health Insurance Company Ltd
Niva Bupa Health Insurance Company Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
T
Transformers and Rectifiers (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
S
Supreme Petrochem Ltd
Supreme Petrochem Ltd shows potential for growth but faces challenges that may impact its performance. Investors should proceed with caution.
View details
E
Elgi Equipments Ltd
Elgi Equipments Ltd shows a decent investment potential with consistent growth and profitability metrics, although some risks and governance concerns exist.
View details
T
Trident Ltd
Trident Ltd shows potential but faces challenges in growth consistency and valuation metrics. Investors should proceed with caution.
View details
F
Fine Organic Industries Ltd
Fine Organic Industries Ltd shows a decent investment potential with strong growth and profitability metrics, but caution is advised due to valuation concerns and some governance issues.
View details
S
Swan Corp Ltd
Swan Corp Ltd presents several risks and lacks strong growth and profitability metrics, making it a risky investment.
View details
Business Overview
The UTI S&P BSE Sensex ETF is a passive investment option designed for investors looking to gain exposure to the top 30 companies listed on the Bombay Stock Exchange. Ideal for both new and seasoned investors, this ETF offers a simple way to diversify your portfolio with minimal effort. By tracking the performance of the Sensex, it provides a transparent and cost-effective means to invest in India's economic growth.
- Tracks the performance of the BSE Sensex.
- Ideal for long-term investors seeking diversification.
- Low expense ratio compared to actively managed funds.
- Provides exposure to India's leading companies.
- Suitable for both beginners and experienced investors.
Investment Thesis
UTI S&P BSE Sensex ETF stands out due to its strong backing from a reputable promoter group, ensuring credibility and trust. The ETF is well-positioned to capitalize on the growing demand for digital investment services in India. With attractive valuations compared to its peers, it presents a compelling opportunity for retail investors seeking exposure to the Indian equity market.
- Strong promoter group enhances credibility and investor confidence.
- Significant growth potential in digital investment services.
- Attractive valuation compared to similar ETFs in the market.
- Diversified exposure to top companies in the Sensex index.
- Ideal for long-term investors looking for stable returns.
Opportunity vs Risk
Opportunities
- Diversified exposure to top Indian companies
- Potential for long-term capital appreciation
- Low expense ratio compared to mutual funds
- Tax efficiency for long-term investors
Risks ⚠️
- Market volatility affecting returns
- Economic downturns impacting performance
- Currency fluctuations for foreign investors
- Limited active management in ETF
Peer Perspective
UTI S&P BSE Sensex ETF trades at a slight premium compared to peers like Nippon India Nifty ETF and ICICI Prudential Nifty ETF; a stable margin and consistent growth could trigger a rerating.
Future Outlook
The UTI S&P BSE Sensex ETF is well-positioned for growth, driven by India's economic resilience; however, successful execution and cost control will be crucial to maximizing returns for retail investors.
AI FAQs for Retail Users
- Q: What is UTI S&P BSE Sensex ETF?A: It is an exchange-traded fund that tracks the performance of the S&P BSE Sensex index.
- Q: How can I invest in this ETF?A: You can invest through a brokerage account that offers access to exchange-traded funds.
- Q: What are the benefits of investing in this ETF?A: It provides diversification and exposure to the top companies in the Indian stock market.
- Q: Are there any risks involved?A: Yes, like all investments, it carries market risks and the value may fluctuate.
- Q: What is the expense ratio of this ETF?A: The expense ratio is a fee charged for managing the fund, which varies by ETF.
📊 Stock Investment Checklist (100 Points)
UTI S&P BSE Sensex ETF • Updated: 2025-09-18 01:28:14
-
10BusinessHighThe ETF tracks a well-established index, providing exposure to a diverse set of companies.
-
10GrowthHighThe underlying index has shown consistent growth, reflecting the overall market performance.
-
10ProfitabilityHighThe ETF's performance is tied to the profitability of its constituents, which have stable ROE.
-
8ValuationHighValuation metrics are in line with the market average, indicating fair pricing.
-
7BalanceHighThe ETF has a low expense ratio and is backed by a strong portfolio.
-
6GovernanceGoodManagement has a good track record, but transparency could be improved.
-
5DriversGoodMarket conditions and economic policies are key drivers, but risks exist.
-
5TechnicalsGoodCurrent market sentiment is neutral with moderate liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
The UTI S&P BSE Sensex ETF is a decent investment option for those looking for exposure to the Indian equity market, with a balanced risk-reward profile.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 75/100